Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
FGFR2 amplification
i
Other names:
FGFR2, BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25, Fibroblast growth factor receptor 2
Associations
(23)
News
Trials
C2 | Sensitive
C3 | Sensitive
D | Sensitive
C2 | Resistant
C3 | Resistant
D | Resistant
Show legend
Include preclinical:
Drug categories
FGF
Tyrosine Kinase Inhibitors
Cyclin Dependent Kinase Inhibitors
Serine-Threonine Kinase Inhibitors
CD Protein Inhibitors
Other
Cancel
Gastric Cancer
Breast Cancer
Gastroesophageal Cancer
Triple Negative Breast Cancer
Hormone Receptor Positive Breast Cancer
Gastroesophageal Junction Adenocarcinoma
Cholangiocarcinoma
Gastric Adenocarcinoma
Colorectal Cancer
Non Small Cell Lung Cancer
infigratinib
C2
FGFR2 amplification
|
Gastric Cancer
|
infigratinib
C2
FGFR2 amplification
|
Breast Cancer
|
infigratinib
C2
FGFR2 amplification
|
Gastroesophageal Junction Adenocarcinoma
|
infigratinib
futibatinib
C2
FGFR2 amplification
|
Gastric Cancer
|
futibatinib
C2
FGFR2 amplification
|
Breast Cancer
|
futibatinib
C2
FGFR2 amplification
|
Triple Negative Breast Cancer
|
futibatinib
D
FGFR2 amplification
|
Gastric Adenocarcinoma
|
futibatinib
Debio 1347
C3
FGFR2 amplification
|
Gastric Cancer
|
Debio 1347
C3
FGFR2 amplification
|
Breast Cancer
|
Debio 1347
ARQ 087
C2
FGFR2 amplification
|
Cholangiocarcinoma
|
ARQ 087
ABSK091
C2
FGFR2 amplification
|
Gastroesophageal Cancer
|
ABSK091
AMG 552
C2
FGFR2 amplification
|
Gastric Cancer
|
AMG 552
TKI258
C3
FGFR2 amplification
|
Breast Cancer
|
TKI258
palbociclib + BAY 1163877
C3
FGFR2 amplification
|
Hormone Receptor Positive Breast Cancer
|
palbociclib + BAY 1163877
ponatinib
D
FGFR2 amplification
|
Gastric Cancer
|
ponatinib
D
FGFR2 amplification
|
Breast Cancer
|
ponatinib
D
FGFR2 amplification
|
Colorectal Cancer
|
ponatinib
FGFR inhibitor
C3
FGFR2 amplification
|
Gastric Cancer
|
FGFR inhibitor
eFT226
D
FGFR2 amplification
|
Breast Cancer
|
eFT226
D
FGFR2 amplification
|
Colorectal Cancer
|
eFT226
D
FGFR2 amplification
|
Non Small Cell Lung Cancer
|
eFT226
erdafitinib
D
FGFR2 amplification
|
Gastric Cancer
|
erdafitinib
nintedanib
D
FGFR2 amplification
|
Gastric Adenocarcinoma
|
nintedanib
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
